《冠心病患者應(yīng)該吃什么藥物（what drugs should coronary heart disease patients take）》由會(huì)員上傳分享，免費(fèi)在線閱讀，更多相關(guān)內(nèi)容在教育資源-天天文庫(kù)。

1、冠心病患者應(yīng)該吃什么藥物（Whatdrugsshouldcoronaryheartdiseasepatientstake）Role1//-//VWLily//-//50//-//0//-//Role2//-//VWPaul//-//100//-//0//-//Role3//-////-//100//-//0//-//Role4//-////-//100//-//0//-//Role5//-////-//100//-//0//-//Role6//-////-//100//-//0//-//<#~-~(^_^~-~

2、#>)inpatientswithcoronaryheartdiseaseshouldeatwhatmedicine?Simvastatin,alsoknownassimvastatin,isacholesterolloweringdrug.Theresearchersfoundthatinadditiontoreducingcholesterol,thereisasignificantroleinstabilizingcalciumplaquesinthecoronaryarteries,Reducecard

3、iovascularevents,coronaryheartdiseasepatientshavegreatbenefits,butithasagreatersideeffectontheliver,theauthorthroughpractice,foundthedoseof5mg,sideeffectsVerysmall,onceaday.Recommendcoronaryheartdiseasepatientswithoneuse.Therelatedarticlesarereproducedasfoll

4、ows:Simvastatin(simvastatin)canbenefitallpatientswithhighcholesterollevelsathighriskofcoronaryheartdiseaseAclinicalstudyofcholesterolregulation,thelargestintheworldsofar,hasshownthatsimvastatinisariskfactorforcoronaryheartdiseaseinpatientswithhighriskfactors

5、(sulpiride)cansavelivesandsignificantlyreducetheincidenceofheartdiseaseandstroke.ThesebenefitsareevenwhencholesterollevelsarenormalinthestudygroupThesameistrueofpatientswhoarebelownormal.Inaddition,thestudydemonstratedthatsomepeoplewithspecialriskfactors,inc

6、ludingdiabeticpatients,strokePatients,womenandtheelderlycanalsosavetheirlives.TheresultsoftheheartprotectionstudywerepublishedinJuly6,2002TheInternationalJournalofmedicine,thelancet.ThestudywasconductedbytheUniversityofOxford.Atotalof20536patientswereenrolle

7、d.Theresultsshowedthatregardlessofgender,age,andbaselinecholesterollevelsHowabout40mgperday,withanaveragereductionofabout1/4inheartdiseaseandstrokeduringanaverageof5.3yearsoftreatment?.RemoveAfterthenoncompliance(unintentionalorunintendedmedication)cases,the

8、researchersestimatedthattheriskinthestudysubjectscouldbereducedby1/3.Themainendpointofthestudy,conductedat69hospitalsintheUK,showedveryimportantresults,withatotalmortalityreductionof13%andmortal